Write You
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > The New 'Four Horseman' of Technology - Cramer Likes My Stock Picks

Tags

  • cramer
  • would
  • categories
  • developing combination
  • developing combination
  • companies involved

  • Links

  • International Dating - When Love Really Means Going the Distance!
  • Walking Everyday Can Add Years To Your Life!
  • Weight Loss Through Simple Home Remedies
  • Write You - The New 'Four Horseman' of Technology - Cramer Likes My Stock Picks

    I am sure that many of you watch or have watched CNBC’s Mad Mone
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    y with Jim Cramer. Personally I think the screaming and boo-yaa
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    are a little much, but I do watch it on occasion. I like Fast
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    oney much better - it comes on a couple hours later. I am quite
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    honored, because it looks like old Cramer has been sniffing arou
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    d my blog looking for ideas

    Back in the glory days Intel (INTC)
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    Cisco (CSCO), Dell (DELL) and Microsoft (MSFT) were known as th
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    four horseman. They were the “go to” stocks. Owning them were
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    like having your own money tree. However, they have all taken i
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    on the chin since then - Intel and Cisco are down 71% and 67%
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    espectively from their high points in 2000, while Dell and Micro
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    oft are down 54% and 49% respectively since 1999.

    Last week Cra
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    er announced his new "four horseman" of technology: Apple (AAPL)
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    Research in Motion (RIMM), Google (GOOG) and Amazon (AMZN). Tw
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    of those names, Apple and Research in Motion, are the members o
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    my recently formed The Big Spend portfolio. Interestingly Cram
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    r and I converged on those names using two completely different
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    pproaches, but our conclusions are the same. These stocks have
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    he potential to significantly outperform the market and are in t
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    e midst of secular (long term) moves. It’s time to get on board


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.writeyou.org.ua/article/101479/writeyou-The-New-Four-Horseman-of-Technology--Cramer-Likes-My-Stock-Picks.html">The New 'Four Horseman' of Technology - Cramer Likes My Stock Picks</a>

    BB link (for phorums):
    [url=http://www.writeyou.org.ua/article/101479/writeyou-The-New-Four-Horseman-of-Technology--Cramer-Likes-My-Stock-Picks.html]The New 'Four Horseman' of Technology - Cramer Likes My Stock Picks[/url]

    Related Articles:

    Change and The Unproductive Moments During Your Journey

    Using Autoresponders In Your Online Business

    Guidance for Increasing Traffic to a New Website

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com